Maykl C. Snabes, MD, PhD, vice chair of the clinical development of the Pharmaceuticalses BioSante, will present the review of the key division in LibiGel development (the gel testosterone) program inn Endocrine Society 90-e Annual Meeting in San Francisco in the Centre Moscone in Sunday, 15 June, 2008. The Announcement named ” Cardiovascular And Breast Safe Study Libigel inn the missis with Sexual pharmacy pill Disorder of the Desire Hypoactive (HSDD): Project of the Analysis And Descriptions of the Endpoints,” - co-authored investigator and consultant in University Connecticut School Medicine, Consultants of the Berry, and M.D. The Cancerous Centre playwright.

The Conference of the news purpose is organized in Sunday, 15 June, 2008, during which reporters invited to consider the announcement and discuss LibiGel and described analysis in contrast Dr. Snabes.

BioSante CONDUCTS the safe analysis, in post-woman menopausal Attending hypoactive sexual health disorder of the desire (HSDD), on request army. Food and Administration Medicine. The Request - in accordance with call to more safe given from Endocrine Society, medical society to professions, which be focused in endocrine and metabolic disease.

Dr. Snabes noted importance this preceding installing the analysis. “This clinical test to study the long-term effects testosterone inn post-woman menopausal, can have existence one of first big, cardiovascular operated events, studies pre- approvals were undertake in the absence of clear safe signal.”

BioSante EXPECTS that enrolled and is tested aproximately three thousandth posts-womans menopausal between age fifty and eighty and, which has at least once one cardiovascular Resolve into s of the risk. The pharmacy online Primary safe result for this test - an effect of the processing in incidence heartily event, including cardiovascular bound cessation, heart attack, and gale. Incidence invasive breast cancer is a primary safe end co-, and investigators leave also look the favourable breast breast cancer of the masses and non-invasives. The Patients exercise volition are evaluated Because hirsutism, acne, and speech or reactions of the skin, Viewed like well as blood testosterone is justified during each visit of the judgement.

HSDD is CHARACTERIZED low libido and the general revolt of the interest inn sex. If secure place endpoints counter and approves the medicine, LibiGel will become first authorized processing specified for HSDD in menopausal woman. BioSante EXPECTS the approval certain time during 2010 or 2011.

The Feminine sexual dysfunction can arise out of many reasons, including problems relations, use the pharmaceuticalses of the prescription, disease, or chemical imbalances. HSDD ADDRESSES successfully and successfully with testosterone for many years though and to date not approved for this use. inn terminated analysis Phase II LibiGel show choice safety and efficiency. However, recently became interested cardiovascular and cancerous risk bound broad class medicine, amongst him potential cure for FSD. The Safe analysis of the Phase III is intended to confirm long-term safety LibiGel’s.

The Operated analysis studies the effect LibiGel in post-woman drugstore online menopausal inn dose 300 micrograms by means of diem over twelve months. BioSante be SPECIFICALLY focused in heartily regardless and incidence breast cancer. After twelve plans of the months BioSante to apply for approval through New Application Medicine (NDA). requires BioSante to follow the group of the analysis during additional fourty-eight months, after subservience NDA and possible approval to compare mate the warmhearted event and breast cancer between group of the processing and corresponding to group of the womans, who come in the gel

LibiGel - a gel 1% testosterone that woman enclose as quick Viewed like day, in there upper tumbler. Measured pea volume argonon carries through skin quickly, from where he delivers the plc dose testosterone on family.

Though testosterone thought-out as male hormone, he is also discovered in woman onward consistent approaching with there age. The Researchers believe that testosterone will justify, what fall with increasing of the age, can subdue the feminine sexual desire. against instance, woman in her has about spirit testosterone during the time that woman in hits twenty.

number HSDD also increases since age and after determined surgical procedures. Aproximately 14% premenopausal womans between age twenty and fourty-nine registered HSDD, in contrast In the opinion of 26% womans, online pharmacy headstone who surgical have deleted their ovaries. Similarly, incidence HSDD grows before 9% for “naturally” menopausal womans. LibiGel is INTENDED to restore the level testosterone in post-womans menopausal on level, which aa considered normal to support Examine libido.

The Results of the Analysis, which carry the preceding safe information finally must lie to put the safe enxiety On account of processing testosterone inn woman and outstrip to approval of the first safe, efficient agent processing be specifically indicated for HSDD in menopausal woman.